Here are six observations:
1. The global market is expected to be worth $8.44 billion by 2020, up from $5.7 billion in 2015.
2. Increasing healthcare expenditure, a growing awareness of wearable devices, rising demand for minimally invasive surgery and advancing implant technologies will spur market growth.
3. Costliness of new procedures and poor infrastructure will hinder the market, however.
4. The orthobiologics segment holds the most promise in the market, due to an increasing awareness of injuries in sports.
5. The Untied States, Europe and Japan account for three-fourths of the market, due to their large sporting cultures.
6. Smith & Nephew, Arthrex, össur, Stryker, Conmed, Zimmer Biomet, Breg, Mueller Sports Medicine, Tornier, Skins International Trading, Wright Medical Technology, DePuy Mitek, 3M Company Ace Brand, OttoBock Healthcare and DJO Global are key market players.
More articles on devices:
Are Stryker’s hip implants about to be recalled?
Medtronic, Philips Healthcare lead US patient monitoring device market: 5 notes
SpineNevada offers advanced imaging with InMotion Diagnostics — 6 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
